Cingulate (CINGW) Current Taxes (2022 - 2026)
Cingulate's (CINGW) quarterly Current Taxes came in at $106000.0 in Q2 2026, up 3.92% on a YoY basis from $102000.0 in Q2 2025, and up 140.91% quarter-over-quarter from $44000.0 in Q4 2025.
Analysis
Cingulate (CINGW) Current Taxes (2022 - 2026) Analysis & Trends
Cingulate (CINGW) has reported Current Taxes for 5 consecutive years, with $106000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Taxes rose 3.92% year-over-year to $106000.0; the trailing twelve-month figure through Jun 2026 stood at $106000.0 (up 3.92% YoY), and the FY2025 full-year result was $44000.0, down 78.0% from the prior year.
- Current Taxes advanced to $106000.0 in Q2 2026 per CINGW's latest filing, from $44000.0 in the prior quarter.
- Across five years, Current Taxes topped out at $200000.0 in Q4 2024 and bottomed at $34750.0 in Q1 2025.
- Historically, Current Taxes has averaged $93775.2 across 5 years, with a median of $91000.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Current Taxes surged 112.04% in 2023, then tumbled 78.0% in 2025.
- Over 5 years, Current Taxes stood at $56862.0 in 2022, then soared by 112.04% to $120570.0 in 2023, then surged by 65.88% to $200000.0 in 2024, then sank by 78.0% to $44000.0 in 2025, then soared by 140.91% to $106000.0 in 2026.
- According to Business Quant data, Current Taxes over the past three periods registered $106000.0, $44000.0, and $73000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.46 Bn | 623.70 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 440.11 Bn | 433.54 Bn | 12.70 Bn | - |
| 3 | Merck | 365.04 Bn | 357.90 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 266.82 Bn | 259.13 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 653.00 Mn |
| 6 | Sanofi | 52.47 Bn | 45.09 Bn | 10.79 Bn | 1.03 Bn |
| 7 | Revolution Medicines | 44.26 Bn | 44.26 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | 106,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 73,000.00 |
| Jun 30, 2025 | 102,000.00 |
| Mar 31, 2025 | 34,750.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 120,570.00 |
| Dec 31, 2023 | 120,570.00 |
| Dec 31, 2022 | 56,862.00 |